These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19520551)

  • 1. In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii.
    Cordeiro Rde A; Brilhante RS; Rocha MF; Medrano DJ; Monteiro AJ; Tavares JL; de Lima RA; de Camargo ZP; Sidrim JJ
    Int J Antimicrob Agents; 2009 Sep; 34(3):278-80. PubMed ID: 19520551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large-Scale Evaluation of
    Thompson GR; Barker BM; Wiederhold NP
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro inhibitory effect of antituberculosis drugs on clinical and environmental strains of Coccidioides posadasii.
    de Aguiar Cordeiro R; Brilhante RS; Rocha MF; Fechine MA; Camargo ZP; Sidrim JJ
    J Antimicrob Chemother; 2006 Sep; 58(3):575-9. PubMed ID: 16867997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activities of caspofungin, amphotericin B and azoles against Coccidioides posadasii strains from Northeast, Brazil.
    Cordeiro RA; Brilhante RS; Rocha MF; Fechine MA; Costa AK; Camargo ZP; Sidrim JJ
    Mycopathologia; 2006 Jan; 161(1):21-6. PubMed ID: 16389480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of antituberculosis drugs and azoles in vitro against Histoplasma capsulatum var. capsulatum.
    Cordeiro Rde A; Marques FJ; Brilhante RS; Rocha de Castro E Silva K; Mourão CI; Caetano EP; Fechine MA; Ribeiro JF; Castelo-Branco Dde S; de Lima RA; Mesquita JR; Monteiro AJ; Rocha FA; Rocha MF; Sidrim JJ
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4482-4. PubMed ID: 21690286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and in vitro antifungal activity of isoniazid-derived hydrazones against Coccidioides posadasii.
    Cordeiro Rde A; de Melo CV; Marques FJ; Serpa R; Evangelista AJ; Caetano EP; Mafezoli J; de Oliveira Mda C; da Silva MR; Bandeira Tde J; Moreira JL; Brilhante RS; Rocha MF; Sidrim JJ
    Microb Pathog; 2016 Sep; 98():1-5. PubMed ID: 27334293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cotrimoxazole enhances the in vitro susceptibility of Coccidioides posadasii to antifungals.
    Cordeiro Rde A; Astete-Medrano DJ; Marques FJ; Andrade HT; Perdigão Neto LV; Tavares JL; de Lima RA; Patoilo KK; Monteiro AJ; Brilhante RS; Rocha MF; de Camargo ZP; Sidrim JJ
    Mem Inst Oswaldo Cruz; 2011 Dec; 106(8):1045-8. PubMed ID: 22241131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciprofloxacin shows synergism with classical antifungals against Histoplasma capsulatum var. capsulatum and Coccidioides posadasii.
    Brilhante RS; Caetano EP; Sidrim JJ; Cordeiro RA; Camargo ZP; Fechine MA; Lima RA; Castelo Branco DS; Marques FJ; Mesquita JR; Lima DT; Monteiro AJ; Rocha MF
    Mycoses; 2013 May; 56(3):397-401. PubMed ID: 23205615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis.
    Cuenca-Estrella M; Gomez-Lopez A; Buitrago MJ; Mellado E; Garcia-Effron G; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2248-50. PubMed ID: 16723597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.
    Skóra M; Bulanda M; Jagielski T
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5827-9. PubMed ID: 26100698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of caspofungin and voriconazole against clinical isolates of Candida and other medically important yeasts by the CLSI M-44A disk diffusion method with Neo-Sensitabs tablets.
    Carrillo-Muñoz AJ; Quindós G; del Valle O; Santos P; Giusiano G; Ezkurra PA; Estivill MD; Casals JB
    Chemotherapy; 2008; 54(1):38-42. PubMed ID: 18073469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Interactions between Target of Rapamycin Kinase Inhibitor and Antifungal Agents against Aspergillus Species.
    Gao L; Ding X; Liu Z; Wu Q; Zeng T; Sun Y
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3813-6. PubMed ID: 26976874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of mutants in Candida albicans with reduced susceptibility to caspofungin: influence on other antifungal products.
    Soler L; Rodriguez JC; Belda S; Cremades R; Ruiz-Garcia M; Lopez P; Royo G
    J Chemother; 2010 Aug; 22(4):283-4. PubMed ID: 20685636
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species.
    Nishi I; Sunada A; Toyokawa M; Asari S; Iwatani Y
    J Infect Chemother; 2009 Feb; 15(1):1-5. PubMed ID: 19280292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus.
    Cuenca-Estrella M; Gomez-Lopez A; Garcia-Effron G; Alcazar-Fuoli L; Mellado E; Buitrago MJ; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1232-5. PubMed ID: 15728937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic activities of three triazoles with caspofungin against Candida glabrata isolates determined by time-kill, Etest, and disk diffusion methods.
    Kiraz N; Dag I; Yamac M; Kiremitci A; Kasifoglu N; Oz Y
    Antimicrob Agents Chemother; 2010 May; 54(5):2244-7. PubMed ID: 20194697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii.
    Li H; Lu Q; Wan Z; Zhang J
    Int J Antimicrob Agents; 2010 Jun; 35(6):550-2. PubMed ID: 20202797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal interactions within the triple combination of amphotericin B, caspofungin and voriconazole against Aspergillus species.
    O'Shaughnessy EM; Meletiadis J; Stergiopoulou T; Demchok JP; Walsh TJ
    J Antimicrob Chemother; 2006 Dec; 58(6):1168-76. PubMed ID: 17071635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activities of eight antifungal drugs against 106 waterborne and cutaneous exophiala species.
    Najafzadeh MJ; Saradeghi Keisari M; Vicente VA; Feng P; Shamsian SA; Rezaei-Matehkolaei A; de Hoog GS; Curfs-Breuker I; Meis JF
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6395-8. PubMed ID: 24100491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the in vitro kinetic activity of caspofungin against Candida glabrata.
    Nagappan V; Boikov D; Vazquez JA
    Antimicrob Agents Chemother; 2010 Jan; 54(1):522-5. PubMed ID: 19841143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.